Difficulty: Medium
Average Score: 89%
Practice
A 65-year-old female with chronic asthma is prescribed montelukast. Montelukast works by:
Correct answer
A
Rationale
In the context of lifespan pharmacology, the correct answer is A) Blocking leukotriene receptors in the lungs. Montelukast is a leukotriene receptor antagonist commonly used in asthma management. Leukotrienes are inflammatory mediators that play a key role in the pathophysiology of asthma by causing bronchoconstriction, mucus production, and airway inflammation. By blocking leukotriene receptors, montelukast helps to reduce these effects, leading to improved asthma control and symptom management in patients.
Option B) Stimulating beta-2 adrenergic receptors is incorrect because drugs that stimulate beta-2 adrenergic receptors like albuterol are bronchodilators, not leukotriene receptor antagonists.
Option C) Inhibiting the release of histamine from mast cells is incorrect because drugs like antihistamines target histamine receptors, not leukotriene receptors.
Option D) Increasing acetylcholine release in the lungs is incorrect because drugs that increase acetylcholine release would not be indicated in asthma treatment.
Understanding the mechanism of action of medications is crucial for healthcare professionals to make informed decisions when managing patients. In the case of montelukast, knowing that it blocks leukotriene receptors helps healthcare providers understand how this medication works to improve asthma symptoms in patients, particularly in this 65-year-old female with chronic asthma.
Option B) Stimulating beta-2 adrenergic receptors is incorrect because drugs that stimulate beta-2 adrenergic receptors like albuterol are bronchodilators, not leukotriene receptor antagonists.
Option C) Inhibiting the release of histamine from mast cells is incorrect because drugs like antihistamines target histamine receptors, not leukotriene receptors.
Option D) Increasing acetylcholine release in the lungs is incorrect because drugs that increase acetylcholine release would not be indicated in asthma treatment.
Understanding the mechanism of action of medications is crucial for healthcare professionals to make informed decisions when managing patients. In the case of montelukast, knowing that it blocks leukotriene receptors helps healthcare providers understand how this medication works to improve asthma symptoms in patients, particularly in this 65-year-old female with chronic asthma.